Anson Chan sells ASPAC II (ASUUF) shares and warrants for $98,750

Published 16/07/2025, 17:18
Anson Chan sells ASPAC II (ASUUF) shares and warrants for $98,750

Director Anson Chan reported selling 5,000,000 ordinary shares and 8,966,000 warrants of ASPAC II Acquisition Corp. (EXCHANGE:ASUUF) on July 7, 2025. The shares were sold at a price of $0, while the warrants were sold at $1 each. The transaction comes as ASPAC II, currently valued at $64.9 million, trades at $11.49 per share, near its 52-week low of $10.61. InvestingPro analysis indicates the company faces liquidity challenges, with short-term obligations exceeding liquid assets.

The filing indicates that Chan sold his interest in A SPAC II (Holdings) Corp. to Yip Tsz Yan for a total of $98,750. As a result of this transaction, Chan no longer holds any equity interests in A SPAC II (Holdings) Corp. and therefore no longer shares the voting or dispositive power over the Issuer’s shares or warrants held by A SPAC II (Holdings) Corp. Want deeper insights into ASPAC II’s financial health and valuation metrics? InvestingPro subscribers have access to over 30 additional financial metrics and exclusive analysis.

In other recent news, Aspac II Acquisition Corp. announced it has entered into a material definitive agreement involving the issuance of an unsecured promissory note to its sponsor, Aspac II (Holdings) Corp. The note, issued on July 14, 2025, is valued at $152,000 and is payable upon the completion of Aspac II Acquisition Corp.’s initial business combination. The sponsor has the option to convert this note into warrants at a conversion price of $1.00 per warrant, matching the terms of the company’s public warrants. The note, notably, does not bear any interest. Proceeds from this financial maneuver are earmarked for covering various expenses and supporting working capital needs. This development was disclosed in a recent SEC Form 8-K filing by the company. Aspac II Acquisition Corp. is incorporated in the British Virgin Islands and trades its securities on the OTC market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.